Ethical Concerns in the Implementation of DNA Sequencing-Based Noninvasive Prenatal Testing for Fetal Aneuploidy Among Obstetric Professionals in Hong Kong

REFERENCES

• Agarwal, A., L. C. Sayres, M. K. Cho, R. Cook-Deegan, and S. Chandrasekharan. 2013. Commercial landscape of noninvasive prenatal testing in the United States. Prenatal Diagnosis 33(6): 521–31. http://dx.doi.org/10.1002/pd.4101
   PubMed Web of Science ®Google Scholar
• Allyse, M. A., L. C. Sayres, M. Havard, et al. 2013. Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testing. Prenatal Diagnosis 33(7): 656–61. http://dx.doi:10.1002/pd.4144
   Google Scholar
• American College of Obstetricians and Gynecologists. 2012. Noninvasive prenatal testing for fetal aneuploidy. Committee opinion no. 545. Obstetrics and Gynecology 120(6): 1532–4. http://dx.doi.org/10.1097/01.AOG.0000423819.85283.f4
   PubMed Web of Science ®Google Scholar
• Apple Daily. 2013. DNA. Available at: http://hk.apple.nextmedia.com/news/art/20130502/18246742
   Google Scholar
• Benn P., A. R. Chapman, K. Erickson, et al. 2014. Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testing. Prenatal Diagnosis 34(2): 145–52. http://dx.doi.org/10.1002/pd.4272
   PubMed Web of Science ®Google Scholar
• Benn, P., A. Borell, R. Chiu, et al. 2013. Position statement from the aneuploidy screening committee on behalf of the board of the international society for prenatal diagnosis. Prenatal Diagnosis 33(7): 1–2. http://dx.doi.org/10.1002/pd.4139
   PubMed Web of Science ®Google Scholar
• Benn, P. A., and A. R. Chapman. 2010. Ethical challenges in providing noninvasive prenatal diagnosis. Current Opinion in Obstetrics and Gynecology 22(2): 128–34. http://dx.doi.org/10.1097/GCO.0b013e3283372352
   PubMed Web of Science ®Google Scholar
• Bianchi, D. W., R. L. Parker, J. Wentworth, et al. 2014. DNA sequencing versus standard prenatal aneuploidy screening. New England Journal of Medicine 370(9): 799–808. http://dx.doi.org/10.1056/NEJMoa1311037
   PubMed Web of Science ®Google Scholar
• Bianchi, D. W., L. D. Platt, J. D. Goldberg, et al. 2012. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstetrics and Gynecology 119(5): 890–901. http://dx.doi.org/10.1097/AOG.0b013e31824fb482
   PubMed Web of Science ®Google Scholar
• Bloomberg. 2014. Non-invasive prenatal testing (NIPT) market expected to reach usd 3.62 billion globally in 2019: Transparency market research. Available at: http://www.bloomberg.com/article/2014-01-06/ariXrEa7suoY.html
   Google Scholar
• Brar, H., E. Wang, C. Struble, T. J. Musci, and M. E. Norton. 2013. The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy. Journal of Maternal–Fetal and Neonatal Medicine 26(2): 143–5. http://dx.doi.org/10.3109/14767058.2012.722731
   PubMed Web of Science ®Google Scholar
• Chitty, L. S., and D. W. Bianchi. 2013. Noninvasive prenatal testing: The paradigm is shifting rapidly. Prenatal Diagnosis 33(6): 511–13. http://dx.doi.org/10.1002/pd.4136
   PubMed Web of Science ®Google Scholar
• Chiu, R. W. K., R. Akolekar, Y. W. L. Zheng, et al. 2011. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validity study. British Medical Journal 342: c7401. http://dx.doi.org/10.1136/bmj.c7401
   PubMed Web of Science ®Google Scholar
• Chiu, R. W. K., T. K. Lau, T. N. Leung, K. C. K. Chow, D. H. K. Chui, and Y. M. Lo. 2002. Prenatal exclusion of β thalassaemia major by examination of maternal plasma. Lancet 360(9338): 998–1000. http://dx.doi.org/10.1016/S0140-6736(02)11086-5
   PubMed Web of Science ®Google Scholar
• Daniels, G., K. Finning, P. Martin, and E. Massey. 2009. Noninvasive prenatal diagnosis of fetal blood group phenotypes: Current practice and future prospects. Prenatal Diagnosis 29(2): 101–7. http://dx.doi.org/10.1002/pd.2172
   PubMed Web of Science ®Google Scholar
• de Jong, A., W. J. Dondorp, C. E. M. de Die-Smulders, S. G. M. Frints, and G. M. W. R. de Wert. 2009. Non-invasive prenatal testing: Ethical issues explored. European Journal of Human Genetics 18(3): 272–7. http://dx.doi.org/10.1038/ejhg.2009.203
   PubMed Web of Science ®Google Scholar
• de Jong, A., W. J. Dondorp, S. G. M. Frints, C. E. M. de Die-Smulders, and G. M. W. R. de Wert. 2011. Advances in prenatal screening: The ethical dimension. Nature Reviews Genetics 12(9): 657–63. http://dx.doi.org/10.1038/nrg3036
   PubMed Web of Science ®Google Scholar
• Deans, Z., and A. J. Newson. 2011. Should non-invasiveness change informed consent procedures for prenatal diagnosis? Health Care Analysis 19(2): 122–32. http://dx.doi.org/10.1007/s10728-010-0146-8
   PubMed Web of Science ®Google Scholar
• Deans, Z., and A. J. Newson. 2012. Ethical considerations for choosing between possible models for using NIPT for aneuploidy detection. Journal of Medical Ethics 38(10): 614–8. http://dx.doi.org/10.1136/medethics-2011-100180
   PubMed Web of Science ®Google Scholar
• Donley, G., S. C. Hull, and B. E. Berkman. 2012. Prenatal whole genome sequencing: Just because we can, should we? Hastings Center Report 42(4): 28–40. http://dx.doi.org/10.1002/hast.50
   PubMed Web of Science ®Google Scholar
• Ehrich, M., C. Deciu, T. Zwiefelhofer, et al. 2011. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting. American Journal of Obstetrics and Gynecology 204(3): 205.e1–e11. http://dx.doi.org/10.1016/j.ajog.2010.12.060
   Web of Science ®Google Scholar
• Garfield, S. S., and S. O. Armstrong. 2012. Clinical and cost consequences of incorporating a novel non-invasive prenatal test into the diagnostic pathway for fetal trisomies. Journal of Managed Care Medicine 15(2): 34–41.
   Google Scholar
• Gil, M. M., R. Akolekar, M. S. Quezada, B. Bregant, and K. H. Nicolaides. 2014. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: Meta-analysis. Fetal Diagnosis and Therapy 35(3): 156–73. http://dx.doi.org/10.1159/000358326
   PubMed Web of Science ®Google Scholar
• Goldenberg, M. J. 2005. Evidence-based ethics? On evidence-based practice and the “empirical turn” from normative bioethics. BMC Medical Ethics 6: E11. http://dx.doi.org/10.1186/1472-6939-6-11
   PubMedGoogle Scholar
• Gregg, A. R., S. J. Gross, R. G. Best, et al. 2013. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genetics in Medicine 15(5): 395–8. http://dx.doi.org/10.1038/gim.2013.29
   PubMed Web of Science ®Google Scholar
• Hayden, E. C. 2014. Prenatal-screening companies expand scope of DNA tests. Nature 507(7490): 19.
   PubMed Web of Science ®Google Scholar
• Hill, M., K. Finning, P. Martin, et al. 2011. Non-invasive prenatal determination of fetal sex: Translating research into clinical practice. Clinical Genetics 80(1): 68–75. http://dx.doi.org/10.1111/j.1399-0004.2010.01533.x
   PubMed Web of Science ®Google Scholar
• Hill, M., J. Fisher, L. S. Chitty, and S. Morris. 2012. Women's and health professionals' preferences for prenatal tests for Down syndrome: A discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests. Genetics in Medicine 14(11): 905–13. http://dx.doi.org/10.1038/gim.2012.68
   PubMed Web of Science ®Google Scholar
• Hill, M., M. Karunaratna, C. Lewis, F. Forya, and L. Chitty. 2013. Views and preferences for the implementation of non‐invasive prenatal diagnosis for single gene disorders from health professionals in the United Kingdom. American Journal of Medical Genetics Part A 161(7): 1612–8. http://dx.doi.org/10.1002/ajmg.a.35972
   Web of Science ®Google Scholar
• Hudecova, I., D. Sahota, M. M. S. Heung, et al. 2014. Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidies. PloS ONE 9(2): e88484. http://dx.doi.org/10.1371/journal.pone.0088484
   PubMed Web of Science ®Google Scholar
• Kelly, S. E., and H. R. Farrimond. 2012. Non-invasive prenatal genetic testing: A study of public attitudes. Public Health Genomics 15(2): 73–81. http://dx.doi.org/10.1159/000331254
   PubMed Web of Science ®Google Scholar
• Kooij, L., T. Tymstra, and P. V. D. Berg. 2009. The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. Prenatal Diagnosis 29(2): 164–8. http://dx.doi.org/10.1002/pd.2205
   PubMed Web of Science ®Google Scholar
• Langlois, S., and J. A. Brock. 2013. Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. Journal of Obstetrics and Gynaecology Canada 35(2): 177–81.
   PubMedGoogle Scholar
• Lo, Y. M., N. Corbetta, P. F. Chamberlain, et al. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet 350(9076): 485–7. http://dx.doi.org/10.1016/S0140-6736(97)02174-0
   PubMed Web of Science ®Google Scholar
• Morain, S., M. F. Greene, and M. M. Mello. 2013. A new era in noninvasive prenatal testing. New England Journal of Medicine 369(6): 499–501. http://dx.doi.org/10.1056/NEJMp1304843
   PubMed Web of Science ®Google Scholar
• Mujezinovic, F., and Z. Alfirevic. 2007. Procedure-related complications of amniocentesis and chorionic villous sampling: A systematic review. Obstetrics and Gynecology 110(3): 687–94. http://dx.doi.org/10.1097/01.AOG.0000278820.54029.e3
   PubMed Web of Science ®Google Scholar
• Musci, T. J., G. Fairbrother, A. Batey, J. Bruursema, C. Struble, and K. Song. 2013. Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice. Prenatal Diagnosis 33(5): 424–8. http://dx.doi.org/10.1002/pd.4091
   PubMed Web of Science ®Google Scholar
• Nicolaides, K. H., A. Syngelaki, G. Ashoor, C. Birdir, and G. Touzet. 2012. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. American Journal of Obstetrics and Gynecology 207(5): 374.e1–e6. http://dx.doi.org/10.1016/j.ajog.2012.08.033
   Web of Science ®Google Scholar
• Palomaki, G. E., E. M. Kloza, G. M. Lambert-Messerlian, et al. 2011. DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genetics in Medicine 13(11): 913–20. http://dx.doi.org/10.1097/GIM.0b013e3182368a0e
   PubMed Web of Science ®Google Scholar
• Regalado, A. 2013. Reading the DNA of fetuses is the next frontier of the genome revolution. MIT Technology Review. Available at: http://www.technologyreview.com/featuredstory/513691/prenatal-dna-sequencing/.
   Google Scholar
• Royal College of Obstetricians and Gynaecologists. 2014. Non-invasive prenatal testing for chromosomal abnormality using maternal plasma DNA. Scientific impact paper no. 15. Available at: www.rcog.org.uk/files/rcog-corp/SIP_15_04032014.pdf.
   Google Scholar
• Sahota, D. 2014. Cost-effectiveness of NIPT in practice. Course in NIPT Practical Guide Training. Hong Kong: The Chinese University of Hong Kong.
   Google Scholar
• Sayres, L. C., M. Allyse, M. E. Norton, and M. K. Cho. 2011. Cell-free fetal DNA testing: A pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenatal Diagnosis 31(11): 1070–76. http://dx.doi.org/10.1002/pd.2835
   PubMed Web of Science ®Google Scholar
• Skirton, H., and C. Patch. 2013. Factors affecting the clinical use of non‐invasive prenatal testing: a mixed methods systematic review. Prenatal Diagnosis 33(6): 532–41. http://dx.doi.org/10.1002/pd.4094
   PubMed Web of Science ®Google Scholar
• Tischler, R., L. Hudgins, Y. J. Blumenfeld, H. T. Greely, and K. E. Ormond. 2011. Noninvasive prenatal diagnosis: Pregnant women's interest and expected uptake. Prenatal Diagnosis 31(13): 1292–9. http://dx.doi.org/10.1002/pd.2888
   PubMed Web of Science ®Google Scholar
• Twiss, P., M. Hill, R. Daley, and L. S. Chitty. 2014. Non-invasive prenatal testing for Down syndrome. Seminars in Fetal and Neonatal Medicine 19(1): 9–14. http://dx.doi.org/10.1016/j.siny.2013.10.003
   PubMed Web of Science ®Google Scholar
• van den Heuvel, A., L. Chitty, E. Dormandy, et al. 2010. Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Education and Counseling 78(1): 24–28. http://dx.doi.org/10.1016/j.pec.2009.05.014
   PubMed Web of Science ®Google Scholar
• Verweij, E. J., J. M. E. van den Oever, M. A. de Boer, E. M. J. Boon, and D. Oepkes. 2011. Diagnostic accuracy of noninvasive detection of fetal trisomy 21 in maternal blood: A systematic review. Fetal Diagnosis and Therapy 31(2): 81–86. http://dx.doi.org/10.1159/000333060
   PubMed Web of Science ®Google Scholar
• Wilson, K. L., J. L. Czerwinski, J. M. Hoskovec, et al. 2013. NSGC practice guideline: Prenatal screening and diagnostic testing options for chromosome aneuploidy. Journal Genetic Counseling 22(1): 4–15. http://dx.doi.org/10.1007/s10897-012-9545-3
   PubMed Web of Science ®Google Scholar
• Yi, H., N. Hallowell, S. Griffiths, and T. Y. Leung. 2013. Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: A qualitative study with early adopter patients in Hong Kong. PloS ONE 8(11): e81794. http://dx.doi.org/10.1371/journal.pone.0081794
   PubMed Web of Science ®Google Scholar
• Yotsumoto, J., A. Sekizawa, K. Koide, et al. 2012. Attitudes toward non-invasive prenatal diagnosis among pregnant women and health professionals in Japan. Prenatal Diagnosis 32(7): 674–9. http://dx.doi.org/10.1002/pd.3886
   PubMed Web of Science ®Google Scholar